IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems

IL-2家族细胞因子及其受体--IL-7/TSLP系统的生物学

基本信息

项目摘要

The IL-2 receptor and related cytokine receptor systems are being studied to clarify the T cell immune response in normal, neoplastic, and immunodeficient states. Following T-cell activation by antigen, the magnitude and duration of the T-cell immune response is determined by the amount of IL-2 produced, levels of receptors expressed, and time course of each event. The IL-2 receptor contains three chains, IL-2Ra, IL-2Rb, and gc. Dr. Leonard cloned IL-2Ra in 1984, we discovered IL-2Rb in 1986, and reported in 1993 that mutation of the gc chain results in X-linked severe combined immunodeficiency (XSCID, which has a T-B+NK- phenotype) in humans. We reported in 1995 that mutations of the gc-associated kinase, Jak3, result in an autosomal recessive form of SCID indistinguishable from XSCID and in 1998 that T-B+NK+ SCID results from mutations in the IL7R gene. Based on work in our lab and others, gc was previously shown to be shared by the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. In collaboration with Harvey Lodish's lab at MIT, we previously reported the cloning of the receptor for thymic stromal lymphopoietin (TSLP). We then demonstrated that TSLP, counter to the sense of the literature, exerted major actions via CD4+ T cells in both humans and mice, and previously showed with Scott Durum that TSLP and IL-7, which share IL-7Ra as a receptor component, both drive the development of regulatory T cells, and that TSLP also signals via receptors on CD8+ T cells. TSLPR, is most related to gc, and we showed that although both TSLP and IL-7 share the IL-7 receptor alpha chain, the function of TSLP and IL-7 are distinctive. We showed that TSLP promotes CD4 T cell development whereas IL-7 and IL-15, which also share gc, favor CD8 T cell development, and that TSLP plays a critical role in the development of allergic lung inflammation mouse model of asthma, and that CD4+ T cells are essential for its action in that model. In the previous year, we demonstrated and reported that TSLP signals via JAK1 and JAK2 rather than through a Tek family kinase, as had been suggested in the literature to mediate the activation of STAT5 in both human and mouse primary T cells, and that STAT5 mediated TSLP-induced survival and proliferation of CD4+ T cells. We showed that JAK1 associates with IL7R and JAK2 with TSLPR, thus clarifying the basis for TSLP signaling and provided the first example of a cytokine using the combination of JAK1 and JAK2 to mediate the activation of STAT5. We also previously demonstrated that dendritic cells, which were known to respond to TSLP, unexpectedly produce TSLP, including after challenge with house dust mite extract, suggesting a possibly autocrine mechanism for their responsiveness to this cytokine. With Arya Biragyn, we also demonstrated that TSLP produced by human and mouse solid tumors contributes to progression and metastasis in breast cancer and melanoma model systems and that the cancer-romoting action of TSLP is mediated via its action on T cells, with the production of IL-10 and IL-13. In the past year, in a collaborative study with Dr. C. Ellison, it was reported that the lack of functional TSLP Receptors mitigates Th2 polarization and the establishment and growth of 4T1 primary breast tmors but has different effects on tumor quantities in the lung and brain. In the previous year, with N. Hirasawa in Japan, we reported that TSLP responsiveness was required for palifermin-mediated protection from graft versus host disease and that moreover, TSLP was induced by xylene and associated with exacerbation of picryl chloride-induced allergic inflammation, and in the past year, additional studies were reported that TSLP production was induced by nonanoic acid, with exacerbation of allergic inflammation in mice. Overall, these studies have increased our understanding of signaling by gc family cytokines and TSLP, clarifying molecular mechanisms that are relevant to immunodeficiency, allergy, autoimmunity, and cancer, as well as to lymphoid homeostasis.
IL-2受体和相关的细胞因子受体系统正在研究中,以澄清正常,肿瘤和免疫缺陷状态下的T细胞免疫应答。在T细胞被抗原激活后,T细胞免疫应答的幅度和持续时间由产生的IL-2的量、表达的受体水平和每个事件的时间过程决定。IL-2受体含有三条链,IL-2 Ra、IL-2 Rb和gc。伦纳德博士于1984年克隆了IL-2 Ra,我们于1986年发现了IL-2 Rb,并于1993年报道了人类中GC链突变导致X连锁严重联合免疫缺陷(XSCID,具有T-B+NK-表型)。我们在1995年报道了GC相关激酶Jak 3的突变导致与XSCID难以区分的常染色体隐性形式的SCID,并且在1998年报道了T-B+NK+ SCID由IL 7 R基因突变引起。基于我们实验室和其他实验室的工作,先前显示gc被IL-2、IL-4、IL-7、IL-9、IL-15和IL-21的受体共享。 在麻省理工学院的Harvey Lodish实验室的合作下,我们先前报道了胸腺基质淋巴细胞生成素(TSLP)受体的克隆。然后,我们证明了TSLP,与文献的意义相反,在人类和小鼠中通过CD 4 + T细胞发挥主要作用,并且先前与Scott Durum一起表明TSLP和IL-7,它们共享IL-7 Ra作为受体组分,都驱动调节性T细胞的发育,并且TSLP还通过CD 8 + T细胞上的受体发出信号。TSLPR与gc最相关,并且我们表明,尽管TSLP和IL-7共享IL-7受体α链,但TSLP和IL-7的功能是不同的。我们发现TSLP促进CD 4 T细胞发育,而IL-7和IL-15也共享gc,有利于CD 8 T细胞发育,TSLP在哮喘变应性肺部炎症小鼠模型的发展中起关键作用,并且CD 4 + T细胞对其在该模型中的作用至关重要。在过去的一年中,我们证明并报道了TSLP信号通过JAK 1和JAK 2而不是通过Tek家族激酶,如文献中所建议的介导人和小鼠原代T细胞中STAT 5的活化,并且STAT 5介导TSLP诱导的CD 4 + T细胞的存活和增殖。我们发现JAK 1与IL 7 R相关,JAK 2与TSLPR相关,从而阐明了TSLP信号传导的基础,并提供了使用JAK 1和JAK 2的组合来介导STAT 5活化的细胞因子的第一个例子。我们以前也证明,树突状细胞,这是已知的响应TSLP,意外地产生TSLP,包括后的挑战与屋尘螨提取物,这表明一个可能的自分泌机制,他们对这种细胞因子的反应。与Arya Biragyn一起,我们还证明了人和小鼠实体瘤产生的TSLP有助于乳腺癌和黑色素瘤模型系统的进展和转移,并且TSLP的促癌作用是通过其对T细胞的作用介导的,产生IL-10和IL-13。在过去的一年里,在与C。Ellison等人的研究表明,功能性TSLP受体的缺乏可减轻Th 2极化以及4 T1原发性乳腺肿瘤的建立和生长,但具有不同的作用 肺和脑中肿瘤的数量。 去年,与N. Hirasawa在日本的研究中,我们报道了TSLP反应性是帕利佛明介导的保护免于移植物抗宿主病所必需的,而且,TSLP是由二甲苯诱导的,并与苦酰氯诱导的过敏性炎症的加重相关,在过去的一年中,有其他研究报道了TSLP的产生是由壬酸诱导的,并伴有小鼠过敏性炎症的加重。 总体而言,这些研究增加了我们对gc家族细胞因子和TSLP信号传导的理解,阐明了与免疫缺陷、过敏、自身免疫和癌症以及淋巴稳态相关的分子机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Warren J Leonard其他文献

The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
Stat5a 和 Stat5b 在白细胞介素 2 家族细胞因子信号传导中的作用
  • DOI:
    10.1038/sj.onc.1203523
  • 发表时间:
    2000-05-25
  • 期刊:
  • 影响因子:
    7.300
  • 作者:
    Jian-Xin Lin;Warren J Leonard
  • 通讯作者:
    Warren J Leonard
Priming for T helper type 2 differentiation by interleukin 2–mediated induction of interleukin 4 receptor α-chain expression
白细胞介素 2 介导的白细胞介素 4 受体α链表达诱导对 T 辅助 2 型分化的启动
  • DOI:
    10.1038/ni.1656
  • 发表时间:
    2008-09-28
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Wei Liao;Dustin E Schones;Jangsuk Oh;Yongzhi Cui;Kairong Cui;Tae-Young Roh;Keji Zhao;Warren J Leonard
  • 通讯作者:
    Warren J Leonard
JAK3 inhibition—is it sufficient?
JAK3 抑制——这就足够了吗?
  • DOI:
    10.1038/nchembio.2066
  • 发表时间:
    2016-04-19
  • 期刊:
  • 影响因子:
    13.700
  • 作者:
    Warren J Leonard;Suman Mitra;Jian-Xin Lin
  • 通讯作者:
    Jian-Xin Lin

Warren J Leonard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Warren J Leonard', 18)}}的其他基金

Il2 Receptors--molecular Regulation
Il2受体--分子调控
  • 批准号:
    6541726
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
Il-2 Receptors--structure And Function
Il-2受体--结构与功能
  • 批准号:
    6690574
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
Il2 Receptors--molecular Regulation
Il2受体--分子调控
  • 批准号:
    6690575
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
Il-2 Receptors--structure and function
Il-2 受体——结构和功能
  • 批准号:
    6967128
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
Il2 Receptors--molecular regulation
Il2受体--分子调控
  • 批准号:
    6967133
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
IL-2 家族细胞因子和受体——调节机制
  • 批准号:
    8746596
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
IL-2 家族细胞因子及其受体——IL-21 系统的生物学
  • 批准号:
    8939804
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
IL-2 家族细胞因子及其受体——IL-21 系统的生物学
  • 批准号:
    8344812
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
IL-2 Family Cytokines and their Receptors-- Molecular Regulation via GABP
IL-2 家族细胞因子及其受体——通过 GABP 进行分子调控
  • 批准号:
    7735035
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
IL-2 家族细胞因子及其受体——IL-2 系统的生物学
  • 批准号:
    10262667
  • 财政年份:
  • 资助金额:
    $ 43.86万
  • 项目类别:

相似海外基金

3-Dimensional genomic architecture in innate lymphoid cells and allergic inflammation
先天淋巴细胞和过敏性炎症的三维基因组结构
  • 批准号:
    10417585
  • 财政年份:
    2022
  • 资助金额:
    $ 43.86万
  • 项目类别:
The regulatory roles of basophils in skin allergic inflammation by using single-cell RNA-seq analysis
利用单细胞 RNA-seq 分析嗜碱性粒细胞在皮肤过敏性炎症中的调节作用
  • 批准号:
    22K07115
  • 财政年份:
    2022
  • 资助金额:
    $ 43.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Effect of Allergic Inflammation on Ovarian Reserve Loss Associated with Endometrioma
过敏性炎症对子宫内膜异位症相关卵巢储备功能丧失的影响
  • 批准号:
    22K16884
  • 财政年份:
    2022
  • 资助金额:
    $ 43.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
3-Dimensional genomic architecture in innate lymphoid cells and allergic inflammation
先天淋巴细胞和过敏性炎症的三维基因组结构
  • 批准号:
    10650334
  • 财政年份:
    2022
  • 资助金额:
    $ 43.86万
  • 项目类别:
Regulators of Rho GTPases in allergic inflammation: Characterizing the role of RhoGDIs in the release of pro-inflammatory mediators from mast cells
过敏性炎症中 Rho GTP 酶的调节因子:表征 RhoGDI 在肥大细胞释放促炎介质中的作用
  • 批准号:
    475576
  • 财政年份:
    2022
  • 资助金额:
    $ 43.86万
  • 项目类别:
    Studentship Programs
Human secreted IgD: structure, interactions and mechanisms in allergic inflammation and asthma
人类分泌的 IgD:过敏性炎症和哮喘的结构、相互作用和机制
  • 批准号:
    MR/V010557/1
  • 财政年份:
    2021
  • 资助金额:
    $ 43.86万
  • 项目类别:
    Research Grant
The impact of exposure to allergic inflammation on esophageal carcinogenesis
接触过敏性炎症对食管癌发生的影响
  • 批准号:
    10308094
  • 财政年份:
    2020
  • 资助金额:
    $ 43.86万
  • 项目类别:
The impact of exposure to allergic inflammation on esophageal carcinogenesis
接触过敏性炎症对食管癌发生的影响
  • 批准号:
    10112399
  • 财政年份:
    2020
  • 资助金额:
    $ 43.86万
  • 项目类别:
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
  • 批准号:
    10447598
  • 财政年份:
    2020
  • 资助金额:
    $ 43.86万
  • 项目类别:
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
  • 批准号:
    10218031
  • 财政年份:
    2020
  • 资助金额:
    $ 43.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了